首页 | 本学科首页   官方微博 | 高级检索  
检索        

复方芦丁片联合米索前列醇治疗产后出血的临床研究
引用本文:汪革平,李莹,樊敏,陈建琴.复方芦丁片联合米索前列醇治疗产后出血的临床研究[J].现代药物与临床,2019,34(6):1801-1804.
作者姓名:汪革平  李莹  樊敏  陈建琴
作者单位:桂林市第二人民医院 妇产科,广西 桂林,541001;桂林市第二人民医院 妇产科,广西 桂林,541001;桂林市第二人民医院 妇产科,广西 桂林,541001;桂林市第二人民医院 妇产科,广西 桂林,541001
基金项目:广西桂林市科学研究与技术开发计划项目(2016012703-4)
摘    要:目的研究复方芦丁片联合米索前列醇片治疗产后出血的临床疗效。方法选取2016年1月—2018年12月桂林市第二人民医院收治的80例产后出血患者作为研究对象,采用随机数字表法将所有患者分为对照组和治疗组,每组各40例。对照组患者口服米索前列醇片,0.6mg/次;治疗组在对照组治疗的基础上口服复方芦丁片,1片/次,3次/d。7d为1个疗程,两组患者持续治疗2个疗程。观察两组患者的临床疗效,比较两组治疗前后的出血量、止血时间和血清生化指标水平。结果治疗后,治疗组总有效率为97.50%,显著高于对照组的87.50%,两组比较差异具有统计学意义(P0.05)。治疗后,治疗组患者2 h、2~24 h出血量和止血时间均显著低于对照组,两组比较差异具有统计学意义(P0.05)。治疗后,两组一氧化氮(NO)、一氧化氮合酶(NOS)和脑钠素(BNP)水平均显著降低(P0.05);且治疗组血清生化指标水平显著低于对照组(P0.05)。结论复方芦丁片联合米索前列醇片治疗产后出血具有较好的临床疗效,能够降低患者出血量,缩短止血时间,且安全性较高,具有一定的临床推广应用价值。

关 键 词:复方芦丁片  米索前列醇片  产后出血  出血量  出血时间  一氧化氮  一氧化氮合酶  脑钠素
收稿时间:2019/1/30 0:00:00

Clinical study on Compound Rutin Tablets combined with misoprostol in treatment of postpartum hemorrhage
WANG Ge-ping,LI Ying,FAN Min and CHEN Jian-qin.Clinical study on Compound Rutin Tablets combined with misoprostol in treatment of postpartum hemorrhage[J].Drugs & Clinic,2019,34(6):1801-1804.
Authors:WANG Ge-ping  LI Ying  FAN Min and CHEN Jian-qin
Institution:Department of Obstetrics and Gynecology, Second People''s Hospital of Guilin, Guilin 541001, China,Department of Obstetrics and Gynecology, Second People''s Hospital of Guilin, Guilin 541001, China,Department of Obstetrics and Gynecology, Second People''s Hospital of Guilin, Guilin 541001, China and Department of Obstetrics and Gynecology, Second People''s Hospital of Guilin, Guilin 541001, China
Abstract:Objective To study the clinical study of Compound Rutin Tablets combined with Misoprostol Tablets in treatment of postpartum hemorrhage. Methods Patients (80 cases) with postpartum hemorrhage in Second People''s Hospital of Guilin from January 2016 to December 2018 were divided into control and treatment groups by random number table, and each group had 40 cases. Patients in the control group were po administered with Misoprostol Tablets, 0.6 mg/time. Patients in the treatment group were po administered with Compound Rutin Tablets on the basis of control group, 1 tablet/time, three times daily. A course of treatment had 7 d, and patients in two groups were treated for 2 courses. After treatment, the clinical efficacies were evaluated, and bleeding amount, hemostasis time, and serum biochemical index levels in two groups before and after treatment were compared. Results After treatment, the clinical efficacy in the treatment group was 97.50%, which was significantly higher than 87.50% in the control group, and there were differences between two groups (P<0.05). After treatment, the amount of bleeding after 2 h and 2-24 h, and the hemostasis time in the treatment group were significantly lower than those in the control group, and there were differences between two groups (P<0.05). After treatment, the levels of NO, NOS, and BNP in two groups were significantly decreased (P<0.05). And the levels of serum biochemical indexes in the treatment group were lower than those in the control group (P<0.05).Conclusion Compound Rutin Tablets combined with Misoprostol Tablets has good clinical efficacy in treatment of postpartum hemorrhage, can reduce the bleeding amount, and shorten hemostasis time, with high safety, which has a certain clinical application value.
Keywords:Compound Rutin Tablets  Misoprostol Tablets  postpartum hemorrhage  bleeding amount  hemostasis time  NO  NOS  BNP
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号